Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-26

Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI) [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial is evaluating transplantation of human umbilical cord mesenchymal stem cells (HUC-MSCs) for women with primary ovarian insuf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) (Mesenchymal stem cells derived from human umbilical cord)

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Primary Ovarian Insufficiency | Phase 1, Phase 2 | Status: UNKNOWN